Sign in
0K6R Stock Price, Chart, Stats & News
Neurocrine Biosciences, Inc.
Save
Neurocrine Biosciences, Inc. (0K6R) does not currently pay a dividend.
17.13B
Market cap
26.48x
Current P/E
–
Forward P/E
0K6R chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Neurocrine Biosciences, Inc. is a biopharmaceutical company dedicated to the research, development, and commercialization of innovative therapies for a range of neurological, endocrine, and psychiatric conditions. Its established portfolio offers solutions for conditions such as tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids. Foremost among its commercialized offerings is INGREZZA, a VMAT2 inhibitor specifically indicated for treating tardive dyskinesia.
Similar securities
Based on sector and market capitalization
Report issue